[go: up one dir, main page]

EA201991265A1 - Лекарственные формы с отсроченным высвобождением, содержащие диметилфумарат - Google Patents

Лекарственные формы с отсроченным высвобождением, содержащие диметилфумарат

Info

Publication number
EA201991265A1
EA201991265A1 EA201991265A EA201991265A EA201991265A1 EA 201991265 A1 EA201991265 A1 EA 201991265A1 EA 201991265 A EA201991265 A EA 201991265A EA 201991265 A EA201991265 A EA 201991265A EA 201991265 A1 EA201991265 A1 EA 201991265A1
Authority
EA
Eurasian Patent Office
Prior art keywords
delayed delivery
medicinal forms
delivery containing
containing dimethylfumarate
dimethylfumarate
Prior art date
Application number
EA201991265A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of EA201991265A1 publication Critical patent/EA201991265A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к фармацевтической композиции с отсроченным высвобождением, содержащей диметилфумарат и по меньшей мере одно фармацевтически приемлемое вспомогательное вещество.
EA201991265A 2016-11-23 2017-11-22 Лекарственные формы с отсроченным высвобождением, содержащие диметилфумарат EA201991265A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2016/16998A TR201616998A1 (en) 2016-11-23 2016-11-23 DELAYED RELEASE DOSING FORMS WITH DIMETHYL FUMARATE
PCT/EP2017/080120 WO2018095996A1 (en) 2016-11-23 2017-11-22 Delayed release dosage forms comprising dimethyl fumarate

Publications (1)

Publication Number Publication Date
EA201991265A1 true EA201991265A1 (ru) 2019-10-31

Family

ID=60450512

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991265A EA201991265A1 (ru) 2016-11-23 2017-11-22 Лекарственные формы с отсроченным высвобождением, содержащие диметилфумарат

Country Status (4)

Country Link
EP (2) EP3326653A1 (ru)
EA (1) EA201991265A1 (ru)
TR (1) TR201616998A1 (ru)
WO (1) WO2018095996A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201818293A2 (tr) * 2018-11-30 2020-06-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Di̇meti̇l fumarat i̇çeren geci̇kmeli̇ salim sağlayan kapsül
CN113004699B (zh) * 2019-12-20 2022-11-29 洛阳尖端技术研究院 一种硅橡胶及其制品
US20240269084A1 (en) * 2021-06-04 2024-08-15 Zim Laboratories Limited Delayed release compositions of dimethyl fumarate
CN115707456A (zh) * 2021-08-19 2023-02-21 成都百裕制药股份有限公司 一种富马酸二甲酯肠溶微片及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
WO2013076216A1 (en) * 2011-11-24 2013-05-30 Synthon Bv Controlled release particles comprising dimethyl fumarate
SG11201404705YA (en) 2012-02-07 2014-10-30 Biogen Idec Inc Pharmaceutical compositions containing dimethyl fumarate
US9410659B2 (en) * 2014-02-10 2016-08-09 The Boeing Company Automated mobile boom system for crawling robots
ES2713157T3 (es) * 2014-02-28 2019-05-20 Banner Life Sciences Llc Cápsulas blandas entéricas de liberación controlada de ésteres de fumarato
WO2016113754A2 (en) * 2015-01-14 2016-07-21 Leiutis Pharmaceuticals Pvt, Ltd. Novel oral dosage forms of dimethyl fumarate
US20180064653A1 (en) * 2015-03-17 2018-03-08 Hetero Labs Limited Pharmaceutical compositions of dimethyl fumarate
WO2017145036A1 (en) * 2016-02-25 2017-08-31 Aurobindo Pharma Ltd Pharmaceutical compositions comprising dimethyl fumarate

Also Published As

Publication number Publication date
EP3513811A1 (en) 2019-07-24
TR201616998A1 (en) 2018-06-21
WO2018095996A1 (en) 2018-05-31
EP3326653A1 (en) 2018-05-30

Similar Documents

Publication Publication Date Title
MX2019000019A (es) Derivado de glucagon, conjugado del mismo, composicion que comprende el mismo y uso terapeutico del mismo.
MX2018007704A (es) Composicion farmaceutica que comprende lenalidomida amorfa y un antioxidante.
ECSP17084331A (es) Formulaciones farmacéuticas
ECSP17044282A (es) Formulación de relación fija de insulina glargina/lixisenatida
EA201792591A1 (ru) Фармацевтические препараты
IL281177A (en) Dengue fever vaccine unit dose and its administration
PH12016501841A1 (en) Immunosuppressant formulation
EA201991265A1 (ru) Лекарственные формы с отсроченным высвобождением, содержащие диметилфумарат
EA202090542A1 (ru) Высококонцентрированные лекарственные формы придопидина
MX2017000676A (es) Oritavancina de alta pureza y metodo para producir la misma.
JOP20170137B1 (ar) صيغ قابلة للحقن متوازنة فسيولوجياً من فوسنيتوبيتانت
MX2018005358A (es) Comprimido de dosis alta que contiene mesalazina optimizado.
WO2015125152A3 (en) Pharmaceutical compositions of asenapine
EA201991287A1 (ru) Твердые фармацевтические композиции на основе тикагрелора для перорального применения
IN2013MU01985A (ru)
BR112018006206A2 (pt) composição, uso de uma combinação, forma de dosagem fixa farmacêutica, combinação de dosagem fixa, embalagem, e, uso de uma combinação de dose fixa
MX2016014701A (es) (r)-pirlindol y sus sales farmaceuticamente aceptables para uso en medicina.
IN2013MU03370A (ru)
EA201991007A1 (ru) Твердые фармацевтические композиции на основе гидрохлорида луразидона для перорального применения
EP3697393A4 (en) DOSAGE FORMS
EA201691422A1 (ru) Перорально распадающиеся таблетированные составы мемантина
EP3650024A4 (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION
IN2013MU02015A (ru)
IN2014MU00781A (ru)
HK40057280A (en) Dengue vaccine unit dose and administration thereof